Canadian Agency for Drugs and Technologies in Health
From Wikipedia, the free encyclopedia
The Canadian Agency for Drugs and Technologies in Health (CADTH) is a national body that "provides Canada’s federal, provincial and territorial health care decision makers with credible, impartial advice and evidence-based information about the effectiveness and efficiency of drugs and other health technologies." CADTH is the home of Canada's Health Technology Assessment (HTA), the Common Drug Review (CDR), and the Canadian Optimal Medication Prescribing and Utilization Service (COMPUS). The programs of CADTH are funded by the provincial and territorial Ministries of Health (with the exception of Quebec) and by Health Canada.
CADTH's main offices are located in Ottawa, Ontario. There is also an office in Edmonton, Alberta, and individual Liaison Officers located in most provinces.
Before April 2006, CADTH was known as the Canadian Coordinating Office for Health Technology Assessment (CCOHTA).
[edit] See also
- International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH)
- Food and Drug Administration (FDA, USA)
- European Medicines Agency (EMEA, EU)
- Ministry of Health, Labour and Welfare (Japan)
- Health Canada
